The results of one of these studies showed that the expression of a long isoform of LEF-1 predominated in AML cells, whereas normal HSCs expressed a short variant of LEF-1 that lacked a β-catenin binding site [55]. This evidence concerns the gene LEF1 and acute myeloid leukemia.